$MIRM

2 theses

bullish 0%neutral 0%bearish 100%

Avg return (3m)

—

Win rate (3m)

— (0 resolved)

1d 3d 1w 1m 3m 6m 1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Sep 15, 4:30 PM ET

$MIRMSEC Form 4bearish

BJERKHOLT ERIC · CHIEF FINANCIAL OFFICER at Mirum Pharmaceuticals, Inc. · 3h agono track record yet

Sold 9,943 @ $98.37 avg · $978,093 · 2026-09-14

Form 4: BJERKHOLT ERIC sold MIRM

BJERKHOLT ERIC (CHIEF FINANCIAL OFFICER at Mirum Pharmaceuticals, Inc.) reported an open-market sale of 9,943 shares of MIRM at an average $98.37, roughly $978,093, in a Form 4 filed 2026-09-15.

At post $93.90Now $93.900.0% since postedas of Sep 15, 4:30 PM ET

View filing on SEC.gov →

$MIRMSEC Form 4bearish

Howe Jolanda · SVP, GLOBAL CONTROLLER at Mirum Pharmaceuticals, Inc. · 27d agono track record yet

Sold 40,000 @ $100.00 avg · $4,000,000 · 2026-08-18

Form 4: Howe Jolanda sold MIRM

Howe Jolanda (SVP, GLOBAL CONTROLLER at Mirum Pharmaceuticals, Inc.) reported an open-market sale of 40,000 shares of MIRM at an average $100.00, roughly $4,000,000, in a Form 4 filed 2026-08-19.

At post $102.24Now $93.90-8.2% since postedas of Sep 15, 4:30 PM ET

1d-5.1%

3d-5.8%

1w-3.6%

1m—

3m—

6m—

1y—

View filing on SEC.gov →

End of results.